Hormone Replacement Therapy Guidelines

Introduction to Hormone Replacement Therapy

• The American Heart Association recommends hormone replacement therapy primarily for moderate to severe menopausal symptoms in women who are within 10 years of menopause onset and under 60 years of age, while avoiding use in women with contraindications or those at elevated risk for cardiovascular disease or stroke 1

Candidate Selection for Hormone Replacement Therapy

• Ideal candidates for hormone replacement therapy are women under 60 years of age, within 10 years of menopause onset, and without elevated risk for cardiovascular disease, stroke, or breast cancer 1
• Absolute contraindications for hormone therapy include history of hormone-related cancers, active liver disease, history of abnormal vaginal bleeding, previous venous thromboembolism or stroke, and coronary heart disease, as listed by the National Comprehensive Cancer Network 2, 3

Benefits and Risks of Hormone Replacement Therapy

• The benefits of hormone replacement therapy typically outweigh the risks in women under 60 years of age and within 10 years of menopause onset 1
• The benefits of hormone replacement therapy rarely outweigh the risks in women with oral estrogen-containing HRT associated with excess stroke risk 1
• Estrogen-only therapy increases the risk of stroke, deep vein thrombosis, and gallbladder disease 4
• Combined estrogen-progestin therapy increases the risk of coronary heart disease, stroke, pulmonary emboli, and invasive breast cancer, but also decreases the risk of colorectal cancer and hip fractures per 10,000 women per year, as suggested by the American College of Physicians and the American College of Obstetricians and Gynecologists 2, 5, 6
• Estrogen therapy is associated with increased risks of stroke, venous thromboembolism, and in some cases breast cancer, which generally outweigh the benefits for most women except for short-term management of severe menopausal symptoms 7

Hormone Replacement Therapy Regimens

• Typical HRT regimens include:

3, 5

• Transdermal estradiol is preferred over oral formulations due to its safety profile and beneficial effects on lipids, inflammation markers, and blood pressure, as recommended by the American Society of Hematology 8

Non-Hormonal Treatments for Menopausal Symptoms

• SNRIs/SSRIs (venlafaxine preferred) are recommended for vasomotor symptoms, with gabapentin or clonidine as alternatives, as suggested by the American College of Physicians and the American College of Obstetricians and Gynecologists 9
• Non-hormonal treatments, such as paced respiration, meditation, SNRIs and SSRIs, gabapentin, clonidine, acupuncture, lifestyle modifications, and environmental modifications, are effective in managing vasomotor symptoms, as suggested by the American College of Obstetricians and Gynecologists 10, 6

Special Considerations for Hormone Replacement Therapy

• For adolescents requiring pubertal induction, the Endocrine Society recommends gradual dose escalation over 24 months 8
• The American College of Cardiology and the American Heart Association recommend against the use of hormone therapy for secondary prevention of coronary events, due to increased risk of cardiovascular events 11, 12
• Women with premature menopause and thyroid cancer should be offered fertility counseling, with options including oocyte or embryo cryopreservation before cancer treatment, as recommended by the American College of Obstetricians and Gynecologists 13
• Discussing fertility preservation before cancer treatment is recommended when possible, with options including oocyte or embryo cryopreservation, as suggested by the American Society for Reproductive Medicine 13

Monitoring and Follow-up for Hormone Replacement Therapy

• HRT should be continued at least until the average age of natural menopause (around 51 years), with treatment effect evaluated after 3-6 months, and monitoring including initial follow-up at 3 months, annual follow-up thereafter, and assessment of blood pressure, weight, lipid profile, symptom control, and bleeding patterns, as recommended by the American College of Physicians and the American College of Obstetricians and Gynecologists 6, 4
• Providing appropriate counseling and support, including addressing body image concerns and offering sexual counseling, may be beneficial for patients experiencing psychological impact, as suggested by the American College of Obstetricians and Gynecologists 9
• Vaginal moisturizers and lubricants are recommended for daily comfort and sexual activity, respectively, and low-dose vaginal estrogen may be considered if non-hormonal options fail, according to the American College of Obstetricians and Gynecologists 14, 5